Cofactor Genomics’ Immunotherapy Predictive Diagnostic, OncoPrism, Completes Validation and Moves Into Clinical Use in Head and Neck Cancer Patients

[#item_full_content]SAINT LOUIS, Mo.–(BUSINESS WIRE)–Cofactor Genomics, the company bridging the precision medicine gap, today announced successful validation…

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]

[#item_full_content]